Literature DB >> 22091021

1,3-Diallyl-6-bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one.

Siham Dahmani, Youssef Kandri Rodi, Santiago V Luis, Michael Bolte, Lahcen El Ammari.   

Abstract

In the mol-ecule of the title compound, C(12)H(12)BrN(3)O, the fused-ring system is essentially planar, the largest deviation from the mean plane being 0.0148 (3) Å. The two allyl groups are nearly perpendicular to the imidazo[4,5-b]pyridine plane [C-C-N-C torsion angles of 81.6 (4) and -77.2 (4)°] and point in the same direction. The planes through the atoms forming each allyl group are nearly perpendicular to the imidazo[4,5-b]pyridin-2-one system, as indicated by the dihedral angles between them of 80.8 (5) and 73.6 (5)°.

Entities:  

Year:  2011        PMID: 22091021      PMCID: PMC3213442          DOI: 10.1107/S1600536811026869

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For background to the biological activity of substituted imidazopyridines and related compounds, see: Barraclough et al. (1990 ▶); Bavetsias et al. (2007 ▶, 2010 ▶); Coates et al. (1993 ▶); Liu et al. (2008 ▶); Ryabukhin et al. (2006 ▶); Schiffmann et al. (2006 ▶).

Experimental

Crystal data

C12H12BrN3O M = 294.16 Orthorhombic, a = 5.4110 (3) Å b = 25.4205 (12) Å c = 9.3170 (4) Å V = 1281.56 (11) Å3 Z = 4 Mo Kα radiation μ = 3.20 mm−1 T = 273 K 0.52 × 0.32 × 0.14 mm

Data collection

Bruker CCD three-circle diffractometer Absorption correction: multi-scan (SADABS; Bruker, 1997 ▶) T min = 0.202, T max = 0.800 8789 measured reflections 3201 independent reflections 2361 reflections with I > 2σ(I) R int = 0.027

Refinement

R[F 2 > 2σ(F 2)] = 0.036 wR(F 2) = 0.100 S = 1.03 3201 reflections 156 parameters 1 restraint H-atom parameters constrained Δρmax = 0.44 e Å−3 Δρmin = −0.23 e Å−3 Absolute structure: Flack (1983) ▶, 1494 Friedel pairs Flack parameter: 0.040 (17) Data collection: SMART (Bruker, 1997 ▶); cell refinement: SAINT (Bruker, 1997 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶). Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536811026869/om2445sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811026869/om2445Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811026869/om2445Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C12H12BrN3OF(000) = 592
Mr = 294.16Dx = 1.525 Mg m3
Orthorhombic, Pna21Mo Kα radiation, λ = 0.71073 Å
Hall symbol: p 2c -2nCell parameters from 3201 reflections
a = 5.4110 (3) Åθ = 1.6–28.5°
b = 25.4205 (12) ŵ = 3.20 mm1
c = 9.3170 (4) ÅT = 273 K
V = 1281.56 (11) Å3Block, colourless
Z = 40.52 × 0.32 × 0.14 mm
Bruker CCD three-circle diffractometer3201 independent reflections
Radiation source: sealed tube2361 reflections with I > 2σ(I)
graphiteRint = 0.027
phi and ω scansθmax = 28.5°, θmin = 1.6°
Absorption correction: multi-scan (SADABS; Bruker, 1997)h = −6→7
Tmin = 0.202, Tmax = 0.800k = −25→34
8789 measured reflectionsl = −12→12
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.036H-atom parameters constrained
wR(F2) = 0.100w = 1/[σ2(Fo2) + (0.0402P)2 + 0.2176P] where P = (Fo2 + 2Fc2)/3
S = 1.03(Δ/σ)max < 0.001
3201 reflectionsΔρmax = 0.44 e Å3
156 parametersΔρmin = −0.23 e Å3
1 restraintAbsolute structure: Flack (1983), 1494 Friedel pairs
Primary atom site location: structure-invariant direct methodsFlack parameter: 0.040 (17)
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against all reflections. The weighted Rw factor and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on all data will be even larger.
xyzUiso*/Ueq
Br10.99838 (6)0.148410 (15)0.99886 (11)0.07396 (14)
N10.5607 (5)0.19539 (10)0.6617 (3)0.0585 (6)
N20.2257 (4)0.14754 (9)0.5520 (3)0.0541 (6)
N30.2480 (5)0.07428 (9)0.6813 (3)0.0552 (6)
O1−0.0599 (4)0.08103 (10)0.5080 (4)0.0730 (6)
C10.7552 (5)0.14820 (11)0.8523 (3)0.0515 (7)
C20.7283 (6)0.19139 (12)0.7678 (4)0.0592 (8)
H20.83210.21990.78420.071*
C30.6043 (6)0.10361 (12)0.8374 (3)0.0532 (7)
H30.62090.07390.89480.064*
C40.4298 (5)0.10753 (12)0.7306 (3)0.0496 (6)
C50.4169 (6)0.15329 (11)0.6493 (4)0.0489 (6)
C60.1188 (6)0.09843 (13)0.5717 (4)0.0579 (7)
C70.1361 (6)0.18683 (13)0.4530 (4)0.0621 (8)
H7A0.13490.22070.50110.075*
H7B−0.03310.17840.42740.075*
C80.2846 (7)0.19138 (15)0.3195 (4)0.0706 (9)
H80.23710.21730.25480.090 (12)*
C90.4653 (9)0.1641 (3)0.2855 (6)0.0939 (15)
H9A0.52010.13760.34660.113*
H9B0.54610.17010.19890.113*
C100.1712 (7)0.02523 (13)0.7497 (4)0.0694 (9)
H10A0.00910.01560.71370.083*
H10B0.15620.03110.85220.083*
C110.3410 (8)−0.01892 (15)0.7256 (5)0.0771 (10)
H110.3027−0.05030.77170.129 (19)*
C120.5362 (7)−0.01882 (17)0.6479 (6)0.0832 (12)
H12A0.58280.01160.59950.100*
H12B0.6313−0.04910.64000.100*
U11U22U33U12U13U23
Br10.05433 (18)0.1026 (3)0.0649 (2)0.00262 (14)−0.01189 (13)−0.0127 (2)
N10.0564 (13)0.0460 (14)0.0731 (17)−0.0070 (11)−0.0083 (14)0.0032 (13)
N20.0478 (13)0.0545 (14)0.0599 (15)−0.0015 (10)−0.0090 (11)0.0029 (10)
N30.0493 (13)0.0476 (13)0.0686 (15)−0.0089 (10)−0.0042 (12)0.0025 (11)
O10.0564 (12)0.0847 (15)0.0781 (16)−0.0178 (10)−0.0148 (16)−0.0040 (16)
C10.0412 (14)0.0642 (18)0.0489 (15)0.0007 (13)−0.0024 (12)−0.0096 (13)
C20.0507 (16)0.0556 (17)0.071 (2)−0.0074 (13)−0.0041 (15)−0.0080 (15)
C30.0489 (15)0.0567 (17)0.0539 (16)0.0026 (13)0.0034 (14)0.0046 (13)
C40.0416 (14)0.0549 (17)0.0522 (16)−0.0013 (11)0.0038 (12)−0.0024 (13)
C50.0446 (14)0.0454 (16)0.0566 (17)0.0003 (11)−0.0005 (14)−0.0055 (13)
C60.0531 (17)0.0630 (18)0.0575 (17)−0.0051 (14)−0.0016 (15)−0.0051 (15)
C70.0550 (17)0.0651 (19)0.0662 (19)0.0019 (13)−0.0108 (15)0.0016 (15)
C80.077 (2)0.083 (2)0.0523 (17)−0.0094 (19)−0.0090 (18)0.0031 (17)
C90.092 (4)0.119 (4)0.071 (3)0.003 (2)0.017 (2)−0.005 (3)
C100.065 (2)0.062 (2)0.081 (2)−0.0164 (15)0.0003 (19)0.0097 (17)
C110.089 (3)0.056 (2)0.086 (3)−0.0155 (18)0.004 (2)0.0058 (18)
C120.086 (3)0.066 (3)0.098 (3)−0.0118 (17)0.008 (2)−0.014 (2)
Br1—C11.896 (3)C4—C51.390 (4)
N1—C51.328 (4)C7—C81.485 (5)
N1—C21.345 (4)C7—H7A0.9700
N2—C51.383 (4)C7—H7B0.9700
N2—C61.388 (4)C8—C91.240 (6)
N2—C71.444 (4)C8—H80.9300
N3—C41.376 (4)C9—H9A0.9300
N3—C61.381 (4)C9—H9B0.9300
N3—C101.461 (4)C10—C111.467 (6)
O1—C61.218 (4)C10—H10A0.9700
C1—C21.359 (4)C10—H10B0.9700
C1—C31.404 (4)C11—C121.281 (6)
C2—H20.9300C11—H110.9300
C3—C41.375 (5)C12—H12A0.9300
C3—H30.9300C12—H12B0.9300
C5—N1—C2113.5 (3)N2—C7—C8114.0 (3)
C5—N2—C6108.7 (2)N2—C7—H7A108.7
C5—N2—C7126.6 (2)C8—C7—H7A108.7
C6—N2—C7124.5 (3)N2—C7—H7B108.7
C4—N3—C6109.6 (3)C8—C7—H7B108.7
C4—N3—C10125.6 (3)H7A—C7—H7B107.6
C6—N3—C10123.9 (3)C9—C8—C7126.6 (4)
C2—C1—C3122.2 (3)C9—C8—H8116.7
C2—C1—Br1119.3 (2)C7—C8—H8116.7
C3—C1—Br1118.5 (2)C8—C9—H9A120.0
N1—C2—C1124.0 (3)C8—C9—H9B120.0
N1—C2—H2118.0H9A—C9—H9B120.0
C1—C2—H2118.0N3—C10—C11114.1 (3)
C4—C3—C1114.4 (3)N3—C10—H10A108.7
C4—C3—H3122.8C11—C10—H10A108.7
C1—C3—H3122.8N3—C10—H10B108.7
C3—C4—N3133.4 (3)C11—C10—H10B108.7
C3—C4—C5119.3 (3)H10A—C10—H10B107.6
N3—C4—C5107.3 (3)C12—C11—C10127.0 (4)
N1—C5—N2125.5 (3)C12—C11—H11116.5
N1—C5—C4126.7 (3)C10—C11—H11116.5
N2—C5—C4107.8 (2)C11—C12—H12A120.0
O1—C6—N3126.9 (3)C11—C12—H12B120.0
O1—C6—N2126.4 (3)H12A—C12—H12B120.0
N3—C6—N2106.6 (3)
C5—N1—C2—C11.8 (5)N3—C4—C5—N1−179.7 (3)
C3—C1—C2—N1−1.2 (5)C3—C4—C5—N2−179.1 (3)
Br1—C1—C2—N1−179.5 (3)N3—C4—C5—N20.5 (3)
C2—C1—C3—C40.2 (4)C4—N3—C6—O1−176.8 (4)
Br1—C1—C3—C4178.6 (2)C10—N3—C6—O1−7.0 (5)
C1—C3—C4—N3−179.4 (3)C4—N3—C6—N20.7 (3)
C1—C3—C4—C50.0 (4)C10—N3—C6—N2170.5 (3)
C6—N3—C4—C3178.7 (3)C5—N2—C6—O1177.2 (4)
C10—N3—C4—C39.2 (6)C7—N2—C6—O11.4 (5)
C6—N3—C4—C5−0.7 (3)C5—N2—C6—N3−0.4 (3)
C10—N3—C4—C5−170.3 (3)C7—N2—C6—N3−176.1 (3)
C2—N1—C5—N2178.2 (3)C5—N2—C7—C881.6 (4)
C2—N1—C5—C4−1.6 (5)C6—N2—C7—C8−103.5 (3)
C6—N2—C5—N1−179.9 (3)N2—C7—C8—C92.7 (6)
C7—N2—C5—N1−4.3 (5)C4—N3—C10—C11−77.2 (4)
C6—N2—C5—C4−0.1 (3)C6—N3—C10—C11114.7 (4)
C7—N2—C5—C4175.5 (3)N3—C10—C11—C12−3.3 (6)
C3—C4—C5—N10.8 (5)
  6 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Metal-mediated inhibition of Escherichia coli methionine aminopeptidase: structure-activity relationships and development of a novel scoring function for metal-ligand interactions.

Authors:  Rolf Schiffmann; Alexander Neugebauer; Christian D Klein
Journal:  J Med Chem       Date:  2006-01-26       Impact factor: 7.446

3.  Inotropic "A" ring substituted sulmazole and isomazole analogues.

Authors:  P Barraclough; J W Black; D Cambridge; D Collard; D Firmin; V P Gerskowitch; R C Glen; H Giles; A P Hill; R A Hull
Journal:  J Med Chem       Date:  1990-08       Impact factor: 7.446

4.  Cyclic nucleotide phosphodiesterase inhibition by imidazopyridines: analogues of sulmazole and isomazole as inhibitors of the cGMP specific phosphodiesterase.

Authors:  W J Coates; B Connolly; D Dhanak; S T Flynn; A Worby
Journal:  J Med Chem       Date:  1993-05-14       Impact factor: 7.446

5.  Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate.

Authors:  Vassilios Bavetsias; Jonathan M Large; Chongbo Sun; Nathalie Bouloc; Magda Kosmopoulou; Mizio Matteucci; Nicola E Wilsher; Vanessa Martins; Jóhannes Reynisson; Butrus Atrash; Amir Faisal; Frederique Urban; Melanie Valenti; Alexis de Haven Brandon; Gary Box; Florence I Raynaud; Paul Workman; Suzanne A Eccles; Richard Bayliss; Julian Blagg; Spiros Linardopoulos; Edward McDonald
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

6.  Hit generation and exploration: imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases.

Authors:  Vassilios Bavetsias; Chongbo Sun; Nathalie Bouloc; Jóhannes Reynisson; Paul Workman; Spiros Linardopoulos; Edward McDonald
Journal:  Bioorg Med Chem Lett       Date:  2007-10-22       Impact factor: 2.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.